37.9% Stake of Roka Bioscience Inc. (ROKA) Held by NEW ENTERPRISE ASSOCIATES 13 LP Total Shares: 8,941,763


Total Shares:


stated that they own 37.9% of Roka Bioscience Inc. (NASDAQ:ROKA) in a Form 13D/A disclosure that was filed with the SEC on Wednesday, September 28th. The investor owns 8,941,763 shares of the stock worth about $5,661,030. The reporting parties listed on the disclosure included New Enterprise Associates 13, LP, NEA Partners 13, LP, Nea 13 Gp, Ltd, M James Barrett, Peter J Barris, Forest Baskett, Patrick J Kerins, Krishna S Kolluri, David M Mott, Scott D Sandell, Ravi Viswanathan and Harry R Weller. The disclosure is available through EDGAR at this hyperlink.

Roka Bioscience Inc. (NASDAQ:ROKA) traded down 3.3140% during midday trading on Wednesday, hitting $0.6331. The company had a trading volume of 128,653 shares. The stock has a 50 day moving average price of $0.90 and a 200-day moving average price of $0.74. The stock’s market capitalization is $11.32 million. Roka Bioscience Inc. has a 52 week low of $0.50 and a 52 week high of $2.14.

Roka Bioscience (NASDAQ:ROKA) last issued its earnings results on Friday, August 5th. The company reported ($0.43) earnings per share for the quarter. The firm had revenue of $1.82 million for the quarter, compared to the consensus estimate of $1.78 million. Roka Bioscience had a negative net margin of 530.04% and a negative return on equity of 82.40%. On average, equities analysts predict that Roka Bioscience Inc. will post ($2.00) EPS for the current year.

Separately, Zacks Investment Research raised Roka Bioscience from a “sell” rating to a “hold” rating in a research report on Wednesday, July 6th.

Roka Bioscience Company Profile

Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

5 Day Chart for NASDAQ:ROKA

Want to see what other hedge funds are holding ROKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roka Bioscience Inc. (NASDAQ:ROKA).

Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.